One of the key areas of interest for researchers will be to study how GLP-1 agonists might enhance recovery and outcomes for people who have had joint replacement surgery
Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a persons overall risk of developing the disease
Find out what a recent study showed in our Protein Powders, Shakes, and Meal Replacements Review, which includes our Top Picks for protein
45 Meir R, Shamalov K, Sadan T, Motiei M, Yaari G, Cohen CJ, Popovtzer R
Daily GLP-1 injections include liraglutide (Victoza, Saxenda), exenatide immediate-release (Byetta), and lixisenatide (Lyxumia)